Victory Capital Management’s Perspective Therapeutics CATX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-49,420
| Closed | -$158K | – | 2481 |
|
|
2024
Q4 | $158K | Sell |
49,420
-1,040
| -2% | -$3.32K | ﹤0.01% | 2274 |
|
|
2024
Q3 | $674K | Buy |
50,460
+38,690
| +329% | +$517K | ﹤0.01% | 1928 |
|
|
2024
Q2 | $117K | Buy |
+11,770
| New | +$117K | ﹤0.01% | 2274 |
|
|
2023
Q1 | – | Sell |
-15,959
| Closed | -$3.94K | – | 2605 |
|
|
2022
Q4 | $3.94K | Sell |
15,959
-6
| -0% | -$1 | ﹤0.01% | 2574 |
|
|
2022
Q3 | $4K | Sell |
15,965
-3,989
| -20% | -$999 | ﹤0.01% | 2683 |
|
|
2022
Q2 | $6K | Sell |
19,954
-135
| -0.7% | -$41 | ﹤0.01% | 2673 |
|
|
2022
Q1 | $6K | Sell |
20,089
-555
| -3% | -$166 | ﹤0.01% | 2698 |
|
|
2021
Q4 | $8K | Sell |
20,644
-575
| -3% | -$223 | ﹤0.01% | 2736 |
|
|
2021
Q3 | $13K | Sell |
21,219
-1,073
| -5% | -$657 | ﹤0.01% | 2749 |
|
|
2021
Q2 | $18K | Sell |
22,292
-648
| -3% | -$523 | ﹤0.01% | 2711 |
|
|
2021
Q1 | $25K | Buy |
22,940
+8,328
| +57% | +$9.08K | ﹤0.01% | 2709 |
|
|
2020
Q4 | $7K | Buy |
14,612
+3,858
| +36% | +$1.85K | ﹤0.01% | 2523 |
|
|
2020
Q3 | $6K | Sell |
10,754
-620
| -5% | -$346 | ﹤0.01% | 2470 |
|
|
2020
Q2 | $6K | Sell |
11,374
-12,064
| -51% | -$6.36K | ﹤0.01% | 2484 |
|
|
2020
Q1 | $12K | Buy |
+23,438
| New | +$12K | ﹤0.01% | 3246 |
|
|
2019
Q4 | – | Sell |
-12,042
| Closed | -$4K | – | 2734 |
|
|
2019
Q3 | $4K | Buy |
+12,042
| New | +$4K | ﹤0.01% | 3495 |
|